Assistant Professor of Medicine, Section of Hematology/Oncology, University of Chicago

Adam DuVall, MD, MPH, specializes in the diagnosis and treatment of cancer for adolescents and young adults. Dr. DuVall’s training in both adult and pediatric hematology/oncology makes him uniquely qualified to care for patients spanning pediatrics through to adulthood. He primarily focuses on acute leukemias, lymphomas, and complex cancer predisposition syndromes, such as familial platelet disorder, hereditary anemias and bone marrow failure syndromes, Li-Fraumeni syndrome and more. As part of the Adolescent and Young Adult Cancer Program at the University of Chicago, he provides comprehensive cancer care for teenage and young adult patients with cancer.

As a clinician-scientist, Dr. DuVall explores translational and clinical research, finding ways to adapt new treatments/therapies into bedside care for young teens with cancer. His innovative clinical trials bring novel therapies to the forefront of leukemia treatment and his collaboration with basic scientists allows him to examine novel therapeutic options for genetic syndromes. Dr. DuVall also recognizes the impact of cancer therapy on all aspects of his patients’ lives, so he participates in research aimed at decreasing the impact of therapy on the psychosocial development of his patients.

Dr. Duvall serves as a faculty affiliate for AYA CARE and takes a leadership role in facilitating cross-site research activities between Michigan Medicine and UChicago Medicine in AYA research.